Agios Pharmaceuticals, Inc.
AGIO
$29.20
-$1.03-3.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -161.27% | -159.51% | 278.14% | 288.87% | 291.35% |
| Total Depreciation and Amortization | -8.42% | -7.22% | -12.03% | -9.67% | -14.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.45% | 105.84% | -1,610.41% | -1,638.81% | -1,632.94% |
| Change in Net Operating Assets | -67.15% | -332.80% | -82.49% | -22.55% | -3.73% |
| Cash from Operations | 4.33% | -24.54% | -32.43% | -33.49% | -31.68% |
| Capital Expenditure | -156.14% | -337.29% | -235.59% | -211.74% | -68.67% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -100.00% | -96.98% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -100.00% | -- | -- | -- |
| Other Investing Activities | 131.09% | -21.65% | -33.79% | -49.76% | -31.00% |
| Cash from Investing | 3.78% | -53.17% | 32.54% | 14.66% | 51.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -39.93% | 4.92% | -5.46% | 15.48% | 165.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -39.93% | 4.92% | -5.46% | 15.48% | 165.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 207.74% | -185.02% | -1,451.91% | -372.14% | 76.58% |